Bio-Thera Solutions Ltd (688177) - Total Liabilities

Latest as of March 2026: CN¥2.16 Billion CNY ≈ $316.22 Million USD

Based on the latest financial reports, Bio-Thera Solutions Ltd (688177) has total liabilities worth CN¥2.16 Billion CNY (≈ $316.22 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Bio-Thera Solutions Ltd to evaluate the company's liquid asset resilience ratio.

Bio-Thera Solutions Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Bio-Thera Solutions Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Bio-Thera Solutions Ltd balance sheet assets.

Bio-Thera Solutions Ltd Competitors by Total Liabilities

The table below lists competitors of Bio-Thera Solutions Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
NAPCO Security Technologies Inc NASDAQ:NSSC	USA	$28.01 Million
Two Harbors Investments Corp NYSE:TWO	USA	$8.80 Billion
Sonic Automotive Inc NYSE:SAH	USA	$5.14 Billion
UTI Asset Management Company Limited NSE:UTIAMC	India	Rs5.39 Billion
Fras-le S.A SA:FRAS3	Brazil	R$4.46 Billion
TD Power Systems Limited NSE:TDPOWERSYS	India	Rs8.05 Billion
Xiamen Solex High-Tech Industries Co Ltd SHG:603992	China	CN¥1.12 Billion
Camel Group Co Ltd SHG:601311	China	CN¥5.60 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Bio-Thera Solutions Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 688177 net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.67	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	9.64	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.91	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bio-Thera Solutions Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bio-Thera Solutions Ltd (2016–2025)

The table below shows the annual total liabilities of Bio-Thera Solutions Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥1.91 Billion ≈ $279.68 Million	+27.64%
2024-12-31	CN¥1.50 Billion ≈ $219.12 Million	+39.38%
2023-12-31	CN¥1.07 Billion ≈ $157.22 Million	+87.67%
2022-12-31	CN¥572.48 Million ≈ $83.77 Million	+7.96%
2021-12-31	CN¥530.27 Million ≈ $77.60 Million	+36.82%
2020-12-31	CN¥387.56 Million ≈ $56.71 Million	+1.01%
2019-12-31	CN¥383.68 Million ≈ $56.15 Million	+74.85%
2018-12-31	CN¥219.44 Million ≈ $32.11 Million	-19.14%
2017-12-31	CN¥271.39 Million ≈ $39.71 Million	+56.10%
2016-12-31	CN¥173.86 Million ≈ $25.44 Million	--

About Bio-Thera Solutions Ltd

SHG:688177 China Biotechnology

Market Cap

$1.28 Billion

CN¥8.74 Billion CNY

Market Cap Rank

#7926 Global

#1817 in China

Share Price

CN¥21.10

Change (1 day)

+8.99%

52-Week Range

CN¥16.10 - CN¥29.53

All Time High

CN¥71.90